SAVA – cassava sciences, inc. (US:NASDAQ)
Stock Stats
News
Lifshitz Law PLLC Announces Investigations of Cassava Sciences, Inc. (NASDAQ: SAVA), iRhythm Technologies, Inc. (NASDAQ: IRTC), Xponential Fitness, Inc. (NYSE: XPOF), and Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX)
Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross [Yahoo! Finance]
Cassava Sciences, Inc. (NASDAQ: SAVA) had its price target raised by analysts at HC Wainwright from $124.00 to $131.00. They now have a "buy" rating on the stock.
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam [Yahoo! Finance]
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
Form 8-K CASSAVA SCIENCES INC For: May 20
Form 4 CASSAVA SCIENCES INC For: May 20 Filed by: BARBIER REMI
Form 4 CASSAVA SCIENCES INC For: May 20 Filed by: Schoen Eric
Form 4 CASSAVA SCIENCES INC For: May 20 Filed by: Cook Robert Christopher
Form 4 CASSAVA SCIENCES INC For: May 20 Filed by: Kupiec James William
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.